APA (7th ed.) Citation

Cao, Y., Yu, Y., Wang, F., Zhang, K., Jiang, Z., Kang, Q., & Xu, J. (2025). YS-49 activates the PI3K/AKT signaling pathway in MC3T3-E1 cells to enhance osteoblast differentiation and inhibits glucocorticoid-induced bone loss in vivo. BMC Musculoskeletal Disorders, 26(1), 1. https://doi.org/10.1186/s12891-025-09167-w

Chicago Style (17th ed.) Citation

Cao, Yuting, Yifan Yu, Feng Wang, Kunqi Zhang, Zengxin Jiang, Qinglin Kang, and Jia Xu. "YS-49 Activates the PI3K/AKT Signaling Pathway in MC3T3-E1 Cells to Enhance Osteoblast Differentiation and Inhibits Glucocorticoid-induced Bone Loss in Vivo." BMC Musculoskeletal Disorders 26, no. 1 (2025): 1. https://doi.org/10.1186/s12891-025-09167-w.

MLA (9th ed.) Citation

Cao, Yuting, et al. "YS-49 Activates the PI3K/AKT Signaling Pathway in MC3T3-E1 Cells to Enhance Osteoblast Differentiation and Inhibits Glucocorticoid-induced Bone Loss in Vivo." BMC Musculoskeletal Disorders, vol. 26, no. 1, 2025, p. 1, https://doi.org/10.1186/s12891-025-09167-w.